Literature DB >> 16139169

Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2.

Magnus Schou1, Christer Halldin, Victor W Pike, P David Mozley, David Dobson, Robert B Innis, Lars Farde, Håkan Hall.   

Abstract

The binding of the norepinephrine transporter radioligand, (S,S)-[18F]FMeNER-D2, to human brain post-mortem was examined in vitro by whole hemisphere autoradiography. The rank order for the density of labelling was: locus coeruleus>>cortex approximately cerebellum approximately thalamus>caudate approximately putamen. The NET-selectivity of binding was confirmed by co-incubation with desipramine. The dual NET/SERT inhibitor duloxetine also inhibited specific binding, whereas PE2I or citalopram had no evident effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139169     DOI: 10.1016/j.euroneuro.2005.01.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  28 in total

1.  Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.

Authors:  Jean-Dominique Gallezot; David Weinzimmer; Nabeel Nabulsi; Shu-Fei Lin; Krista Fowles; Christine Sandiego; Timothy J McCarthy; R Paul Maguire; Richard E Carson; Yu-Shin Ding
Journal:  Neuroimage       Date:  2010-09-30       Impact factor: 6.556

2.  Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Per Karlsson; Magnus Schou; Anu J Airaksinen; Francois Vandenhende; Johannes Tauscher; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-02       Impact factor: 9.236

3.  Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.

Authors:  Nicholas Seneca; Balázs Gulyás; Andrea Varrone; Magnus Schou; Anu Airaksinen; Johannes Tauscher; Francois Vandenhende; William Kielbasa; Lars Farde; Robert B Innis; Christer Halldin
Journal:  Psychopharmacology (Berl)       Date:  2006-08-04       Impact factor: 4.530

4.  Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain.

Authors:  Vikram Adhikarla; Fanxing Zeng; John R Votaw; Mark M Goodman; Jonathon A Nye
Journal:  Nucl Med Biol       Date:  2016-02-28       Impact factor: 2.408

5.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

6.  Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants.

Authors:  Annette Beatrix Brühl; Lutz Jäncke; Uwe Herwig
Journal:  Psychopharmacology (Berl)       Date:  2011-02-26       Impact factor: 4.530

7.  Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]beta-CIT SPECT analysis.

Authors:  Christoph Scherfler; Sylvia M Boesch; Eveline Donnemiller; Klaus Seppi; Helga Weirich-Schwaiger; Georg Goebel; Irene Virgolini; Gregor K Wenning; Werner Poewe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-13       Impact factor: 9.236

8.  Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand.

Authors:  Janice J Hwang; Catherine W Yeckel; Jean-Dominique Gallezot; Renata Belfort-De Aguiar; Devrim Ersahin; Hong Gao; Michael Kapinos; Nabeel Nabulsi; Yiyun Huang; David Cheng; Richard E Carson; Robert Sherwin; Yu-Shin Ding
Journal:  Metabolism       Date:  2015-03-05       Impact factor: 8.694

9.  SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.

Authors:  Akihiro Takano; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2012-10-23       Impact factor: 4.530

10.  Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.

Authors:  Annette Beatrix Brühl; Tina Kaffenberger; Uwe Herwig
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.